38: Intestinal Autotransplantation for Locally Advanced or Recurrent Right Colon Cancer Invading the Superior Mesenteric Artery
Rattachement africain : cn. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Introduction: Involvement of the superior mesenteric artery (SMA) by locally advanced or recurrent colon cancer is considered inoperable, associated with a dismal prognosis. Attempted resection may lead to uncontrolled massive bleeding, irreversible intestinal ischemic damage, or a noncurative resection (R1 or R2). This study aimed to examine outcomes of intestinal autotransplantation (IATx) alone or IATx plus pancreaticoduodenectomy in patients with right colon cancer invading SMA. Methods: This retrospective cohort study included patients undergoing IATx between May 1999 and December 2021 in intestinal transplant programs in two university-affiliated hospitals in China. Results: A total of ten patients underwent IATx combined with pancreaticoduodenectomy (n=8) or IATx alone (n=2). Eight (80%) were male, and the median age were 55 years (range, 32-71 years). Kaplan-Meier estimates for recurrence-free and overall survival at 3 years after IATx were 80% and 100%, respectively. Postoperatively, 3 patients experienced no complications, whereas 7 experienced Clavien-Dindo complications of grade II (3), grade IIIA (2), and grade IIIB (2) including acute venous thrombosis, upper gastrointestinal bleeding, pleural effusions, and gastropareses. Conclusions: This study’s findings of recurrence-free and overall survival rates suggest that select patients with unresectable, locally advanced or recurrent colon cancer may benefit from IATx.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- 38: Intestinal Autotransplantation for Locally Advanced or Recurrent Right Colon Cancer Invading the Superior Mesenteric Artery
- Date Crossref
- 27/06/2023
- Éditeur
- Ovid Technologies (Wolters Kluwer Health)
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.